SCHEMBL29548205

SCHEMBL29548205

COC1CCN(c2ccc3c(=O)c4cccc(F)c4oc3c2)C1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ MAOA P21397 4/20 0.40
▸ USP30 Q70CQ3 5/20 0.40
▸ CHRNA7 P36544 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ HTR1A P08908 2/20 0.37
▸ HTR7 P34969 2/20 0.37
▸ HTR6 P50406 2/20 0.37
▸ HTR2A P28223 1/20 0.37
▸ MGLL Q99685 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ NTSR1 P30989 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19642415 1.00 MAOA (0.40) MAOAUSP30CHRNA7KCNH2HTR1A
SCHEMBL19642382 1.00 MAOA (0.40) MAOAUSP30CHRNA7KCNH2HTR1A
SCHEMBL19642429 0.84 HSD11B1 (0.40) MAOAKDM4ENPC1ALDH1A1RAB9A
SCHEMBL29547630 0.84 HSD11B1 (0.40) MAOAKDM4ENPC1ALDH1A1RAB9A
SCHEMBL19642412 0.84 KHK (0.40) MAOACHRNA7KCNH2HTR1AHTR7
SCHEMBL19642414 0.84 KHK (0.40) MAOACHRNA7KCNH2HTR1AHTR7
SCHEMBL19642317 0.84 LOXL2 (0.45) MAOACHRNA7KCNH2
SCHEMBL19642244 0.84 LOXL2 (0.45) MAOACHRNA7KCNH2
SCHEMBL19662153 0.84 KHK (0.40) MAOACHRNA7KCNH2HTR1AHTR7
SCHEMBL19662373 0.84 MAOA (0.38) MAOACHRNA7KCNH2HTR1AHTR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109311860-B Xanthone derivatives for the treatment or prevention of hepatitis B virus diseases 豪夫迈·罗氏有限公司 2022-04-08 — — CN claimed
CN-109311860-B Xanthone derivatives for the treatment or prevention of hepatitis B virus diseases 豪夫迈·罗氏有限公司 2022-04-08 — — CN disclosed
Send feedback